liver-cancer

Documents about liver-cancer

• COVID-19 in Immunosuppressed Children#805950ClinicalTrials.gov
• Ph 1 Trial of ADI PEG 20 Plus Sorafenib to Treat Patients With Liver Cancer#837799ClinicalTrials.gov
• HAIC Sequential TAE Combined With Lenvatinib and Tislelizumab in Unresectable HCC#848978ClinicalTrials.gov
• A Study to See Whether Stereotactic Body RadioTherapy (SBRT) Can Shrink Tumours Within the Liver Safely#850592ClinicalTrials.gov
• Safety and Tolerability of I.V. Infusion of MB07133 in Patients With Unresectable Hepatocellular Carcinoma#860104ClinicalTrials.gov
• Sintilimab Combined With Bevacizumab and Liver Protective Support Therapy in Unresectable Hepatocellular Carcinoma#861117ClinicalTrials.gov
• Evaluate the Effect of Tirazamine on Primary Liver Cancer.#875266ClinicalTrials.gov
• Application of Perioperative Remote Ischemic Conditioning in Patients Undergoing Hepatectomy#884998ClinicalTrials.gov
• Circulating Tumor Cell Capture for Early Diagnosis and Postoperative Tumor Recurrence Monitoring of Liver Cancer#889857ClinicalTrials.gov
• Immunophenotype of PBMC to Early Predict Response to Immunotherapy in Hepatocellular Carcinoma#992894ClinicalTrials.gov
• IRX-2, Cyclophosphamide, and Nivolumab in Treating Patients With Recurrent or Metastatic and Refractory Liver Cancer#28310ClinicalTrials.gov
• Phase 2 Study of Daraxonrasib in Recurrent KRAS-Mutant Biliary Tract Cancer#812472ClinicalTrials.gov
• A Phase I Study of Isolated Hepatic Perfusion With Escalating Dose Melphalan Followed by Postoperative Hepatic Arterial Floxuridine and Leucovorin for Metastatic Unresectable Colorectal Cancers of the Liver#915262ClinicalTrials.gov
• Quercetin Alleviates Intestinal and Liver Dysfunction Induced by Hypoxia in a Microphysiological System#196652Figshare
• Advanced Magnetic Resonance Imaging and Thermometry Techniques for Guiding Thermal Therapies#651641eScholarship
• Metabolic Activation-Dependent Anti-Liver Cancer Activity and Organ-Specific Toxicity of Retrorsine From Fanhuncao (Jacobaea cannabifolia and J. litvinovii).#671093NCBI PubMed Central
• Pan-cancer analysis identifies KANSL2 as a cell-cycle-associated regulator of tumor progression and immunity in liver hepatocellular carcinoma.#785586NCBI PubMed Central
• Study of Oncolytic Virus in Combination With HX-008 and Axitinib in Melanoma Patients With Liver Metastasis#804414ClinicalTrials.gov
• Vandetanib-eluting Radiopaque Embolic Beads in Patients With Resectable Liver Malignancies#825248ClinicalTrials.gov
• Prospective Randomised Study of Doxorubicin in the Treatment of Hepatocellular Carcinoma by Drug-Eluting Bead Embolisation#838090ClinicalTrials.gov
• Patient-Derived Xenografts to Reduce Cancer Health Disparities#846245ClinicalTrials.gov
• Evaluate Durvalumab and Tremelimumab +/- Lenvatinib in Combination With TACE in Patients With Locoregional HCC#868361ClinicalTrials.gov
• Pilot Study of an Implantable Microdevice for In Situ Evaluation of Drug Response in Patients With Colorectal Liver Metastasis#890786ClinicalTrials.gov
• A Study to Assess the Safety, Tolerability, and Pharmacokinetics of ABSK-011 in Patients With Advanced Solid Tumor#1032871ClinicalTrials.gov
• Effect of Sarcopenia on HCC After Lenvatinib and Anti-PD-1 Treatment#1046992ClinicalTrials.gov
• A Study of T3011 Administered Via Intravenously in Patients With Advanced Solid Tumors.#836155ClinicalTrials.gov
• Study of Radiotherapy and Pembrolizumab in People With Adrenocortical Carcinoma#903722ClinicalTrials.gov
• Ropidoxuridine in Treating Patients With Advanced Gastrointestinal Cancer Undergoing Radiation Therapy#854918ClinicalTrials.gov
• A new inject-embed 3D culture method enables the spheroid and aggregate formation from single or dual liver cancer cell types.#13663NCBI PubMed Central
• Asian Burden of Liver Cancer 1990-2021 and Predictions to 2040: An Analysis of the Global Burden of Disease Study 2021.#150098NCBI PubMed Central
• Primary liver cancer at tertiary healthcare facility in Guinea: a cross-sectional study#284225HAL (France)
• Development and validation of a machine learning model to evaluate survival in patients with newly diagnosed breast cancer with liver metastasis.#330813NCBI PubMed Central
• Study on the Effectiveness and Safety of Carrelizumab Combined With Apatinib Mesylate and Radiotherapy in the Treatment of Advanced Liver Cancer#442097ClinicalTrials.gov
• Ru(II)-based complexes containing 2-thiouracil derivatives suppress liver cancer stem cells by targeting NF-κB and Akt/mTOR signaling.#647223REPOSITORIO INSTITUCIONAL DA UFOP
• A SEER based SHAP interpretable prognostic nomogram for overall survival in surgically treated patients with colorectal cancer and synchronous liver metastasis.#685555NCBI PubMed Central
• Sorafenib vs.TransArterial Chemoembolization Plus RadioTherapy in Hepatocellular Carcinoma With Macrovascular Invasion#837459ClinicalTrials.gov
• A Safety and Efficacy Study of DENSPM in Patients With Liver Cancer Who Are Not Eligible for Surgical Care#849112ClinicalTrials.gov
• Sorafenib Plus Doxorubicin in Patients With Advanced Hepatocellular Carcinoma With Disease Progression on Sorafenib#878150ClinicalTrials.gov
• MLN0128 Compared to Sorafenib in Advanced or Metastatic Hepatocellular Carcinoma#880171ClinicalTrials.gov
• Open-label Multicenter Phase 1 Study of TBI 302 as Second-Line Therapy in Patients With Hepatocellular Carcinoma#901838ClinicalTrials.gov
• Measurement of Pro-angiogenic Markers in Patients With Hepatic Metastases Undergoing SIRT#902410ClinicalTrials.gov
• Study to Assess the Blood Levels and Safety of Olaparib in Patients With Advanced Solid Tumours and Normal Liver Function or Mild or Moderate Liver Impairment#802511ClinicalTrials.gov
• ALTUS: Performance of a Multi- Target Hepatocellular Carcinoma (HCC) Test in Subjects With Increased Risk#873231ClinicalTrials.gov
• Reversal of cancer gene expression correlates with drug efficacy and reveals therapeutic targets#491853eScholarship
• Study to Assess the Blood Levels and Safety of AZD9291 in Patients With Advanced Solid Tumours and Normal Liver Function or Mild or Moderate Liver Impairment#879697ClinicalTrials.gov
• Primary liver cancer in Georgia: Seven years’ experience following the launch of the Hepatitis C Elimination Program, 2015–2022#149912Unpaywall
• Global trends and thematic evolution of nursing in liver cancer: a bibliometric analysis of the web of science core collection (1944-2025).#157127NCBI PubMed Central
• Liver Cancer and Immunotherapy in the Liquid Biopsy Era#208450ClinicalTrials.gov
• Global, Regional, and National Burden of Liver Cancer from 1990 to 2021 and Projections to 2050: A Global Burden of Disease Study 2021.#371592NCBI PubMed Central
• Engineering of episomal plasmid structure to enhance non-viral Poly(beta-amino ester) nanoparticle gene delivery to liver and brain cancer cells.#395947NCBI PubMed Central